Abstract
Background
Fibrin sealant is a two-component topical hemostat, sealant, and tissue adhesive consisting of fibrinogen and thrombin that has been used in the United States as a blood bank- or laboratory-derived product since the 1980s and has been commercially available since 1998.
Methods/results
Initially, surgeons employed hospital-based materials because of the lack of availability of a commercially produced agent. At present, there are five U.S. Food and Drug Administration (FDA)-approved forms including products derived from pooled or autologous human plasma as well as bovine plasma. On-label indications include hemostasis, colonic sealing, and skin graft attachment. Recent clinical and experimental uses include tissue or mesh attachment, fistula closure, lymphatic sealing, adhesion prevention, drug delivery, and tissue engineering.
Conclusions
The modern literature on fibrin sealant now exceeds 3000 articles and continues to expand. This brief review presents the history of this material, its present clinical use, and its future applications.
Similar content being viewed by others
References
Spotnitz WD, Burks S (2008) Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 48:1502–1516
Spotnitz WD, Prabhu R, Welker R (2004) Clinical uses of fibrin sealant. In: Mintz PD et al (eds) Transfusion therapy: clinical principles and practice, 2nd edn. AABB Press, Bethesda, MD, pp 437–477
Bergel S (1909) Uber wirkungen des fibrins. Dtsch Med Wochenschr 35:633
Young JZ, Medawar PB (1940) Fibrin suture of peripheral nerves. Lancet 275:126–132
Cronkite EP, Lozner EL, Deaver J (1944) Use of thrombin and fibrinogen in skin grafting. JAMA 124:976–978
Matras H, Dings HP, Manoli B et al (1972) Zur nachtlosen Interfaszikularen Nerventransplantation im Tierexperiment. Wein Med Wochenschr 122:517–523
Spotnitz WD, Welker R (1999) Clinical uses of fibrin sealant. In: Mintz PD (ed) Transfusion therapy: clinical principles and practice, 1st edn. AABB Press, Bethesda, MD, pp 199–222
Dresdale A, Rose EA, Jeevanandam V et al (1985) Preparation of fibrin glue from single-donor fresh-frozen plasma. Surgery 97:750–755
Matthew TL, Spotnitz WD, Kron IL et al (1990) Four years experience with fibrin sealant in thoracic and cardiovascular surgery. Ann Thorac Surg 50:40–44
Siedentop KH, Harris DM, Sanchez B (1985) Autologous fibrin tissue adhesive. Laryngoscope 95:1074–1076
Spotnitz WD, Mintz PD, Avery N et al (1987) Fibrin glue from stored human plasma: an inexpensive and efficient method for local blood bank preparation. Am Surg 53:460–464
Spotnitz WD (1995) Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost 74:482–485
Spotnitz WD, Burks SG, Prabhu R (2005) Fibrin-based adhesives and hemostatic agents. In: Quinn JV (ed) Tissue adhesives in clinical medicine. BC Decker, Hamilton, Ontario, Canada, pp 77–112
Chung W, Kazemi P, Ko D et al (2009) Anal fistula plug and fibrin glue versus conventional treatment in repair of complex anal fistulas. Am J Surg 197:604–608
Ruggiero R, Procaccini E, Gili S et al (2008) Fibrin glue to reduce seroma after axillary lymphadenectomy for breast cancer. Minerva Chir 63:249–254
Fortelny RH, Schwab R, Glaser KS et al (2008) The assessment of quality of life in a trial on lightweight mesh fixation with fibrin sealant in transabdominal preperitoneal hernia repair. Hernia 12:499–505
Garcia-Olmo D, Herreros D, Pascual I et al (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79–86
Zhibo X, Miaobo Z (2009) Effect of sustained-release lidocaine on reduction of pain after subpectoral breast augmentation. Aesthet Surg J 29:32–34
Ishii I, Mizuta H, Sei A et al (2007) Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br 89:693–700
Leong DT, Nah WK, Gupta A et al (2008) The osteogenic differentiation of adipose tissue-derived precursor cells in a 3D scaffold/matrix environment. Curr Drug Discov Technol 5:319–327
Schillinger U, Wexel G, Hacker C et al (2009) A fibrin glue composition as carrier for nucleic acid vectors. Pharm Res 25:2946–2962
Acknowledgment
The author thanks Dr. Eric Rose for his interest in fibrin sealant at the Columbia Presbyterian Medical Center during the1980s, which facilitated the author’s exploration of the clinical and experimental use of this material.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spotnitz, W.D. Fibrin Sealant: Past, Present, and Future: A Brief Review. World J Surg 34, 632–634 (2010). https://doi.org/10.1007/s00268-009-0252-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-0252-7